EPE1004 Preferred models of clinical service delivery for HIV pre-exposure prophylaxis (PrEP) users in the COVID-19 era: a discrete choice experiment among men who have sex with men (MSM) in AustraliaE-posterImpact of COVID-19 on HIV prevention, testing and treatment (including financing)
EPE1005 Compounding factors that affected viral load scale-up and viral load coverage in Kenya, before and during the COVID-19 pandemicE-posterImpact of COVID-19 on HIV prevention, testing and treatment (including financing)
EPE1006 Identifying the drivers and influencers of COVID-19 vaccine hesitancy in NigeriaE-posterImpact of COVID-19 on HIV prevention, testing and treatment (including financing)
EPE1007 Delivering HIV pre-exposure prophylaxis to people who use drugs experiencing homelessness during the COVID-19 pandemicE-posterImpact of COVID-19 on HIV prevention, testing and treatment (including financing)
EPE1008 PrEP use behaviors and sexual health in China during COVID-19 lockdownsE-posterImpact of COVID-19 on HIV prevention, testing and treatment (including financing)
EPE1009 The effect of Covid-19 on HIV services at HIV-care clinics in MyanmarE-posterImpact of COVID-19 on HIV prevention, testing and treatment (including financing)
EPE1010 Changes in HIV service utilization and care outcomes during the first year of the COVID-19 pandemic in Central Africa IeDEA sitesE-posterImpact of COVID-19 on HIV prevention, testing and treatment (including financing)
EPE1011 Implementation of person-centered strategies to improve reengagement in care in Mumbai, IndiaE-posterImpact of COVID-19 on HIV prevention, testing and treatment (including financing)
LBEPA01 Large decrease in the proportion of newly diagnosed HIV-1 infections grouping in large clusters in SpainE-posterHIV virology
LBEPA02 Immune responses to respiratory syncytial virus among HIV-exposed uninfected infants from the United States correlate with maternal inflammation during pregnancyE-posterHost immune responses, vaccines and immunotherapies
1131 - 1140 of 1427 items